Name
IL23R GENE POLYMORPHISM AS A PREDICTOR OF RESPONSE TO USTEKINUMAB (STELARA) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Topic
Inflammatory Bowel Diseases: Mechanisms and Treatments
Group
CDDW
Number
A265
Presenter
Zaki Alhashimalsayed
Poster Session
Poster Session II
Date
Saturday, February 28th 2026
Time
18h00-19h00